Insider filing · CBIO
Joshua T Brumm
Chief Executive Officer
profile →
Crescent Biopharma, Inc.
CBIO · Healthcare · 5 filings in 24 months
ticker →
Joshua T Brumm sold $761K of Crescent Biopharma (CBIO)
Executed Jun 22, disclosed Jun 23, 1 day later.
Value, as filed
$761K
42,305 sh × $17.99
Executed
Jun 22
the trade date, as filed
Disclosed
Jun 23
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JBJoshua T Brumm (Chief Executive Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Crescent Biopharma, Inc. (CBIO). The largest single filing was $761K of CBIO (42,305 sh × $17.99, as filed), executed Jun 22.
The name
CBIOHealthcare · Crescent Biopharma, Inc., a biotechnology company, researches and develops cancer therapy candidates in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Joshua T Brumm in CBIO
CBIOSALE
Crescent Biopharma, Inc.
$131K7,837 sh × $16.71
Exec Sep 18
Filed Sep 18 · 4:02 PM ET